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Background: Previous studies have shown the effect of a unique therapy with a non-invasive biomechanical foot-worn
device (AposTherapy) on Caucasian western population suffering from knee osteoarthritis. The purpose of the current
study was to evaluate the effect of this therapy on the level of symptoms and gait patterns in a multi-ethnic
Singaporean population suffering from knee osteoarthritis.
Methods: Fifty-eight patients with bilateral medial compartment knee osteoarthritis participated in the study.
All patients underwent a computerized gait test and completed two self-assessment questionnaires (WOMAC
and SF-36). The biomechanical device was calibrated to each patient, and therapy commenced. Changes in
gait patterns and self-assessment questionnaires were reassessed after 3 and 6 months of therapy.
Results: A significant improvement was seen in all of the gait parameters following 6 months of therapy.
Specifically, gait velocity increased by 15.9%, step length increased by 10.3%, stance phase decreased by 5.9%
and single limb support phase increased by 2.7%. In addition, pain, stiffness and functional limitation
significantly decreased by 68.3%, 66.7% and 75.6%, respectively. SF-36 physical score and mental score also
increased significantly following 6 months of therapy (46.1% and 22.4%, respectively) (P < 0.05 for all parameters).
Conclusions: Singaporean population with medial compartment knee osteoarthritis demonstrated improved gait
patterns, reported alleviation in symptoms and improved function and quality of life following 6 months of therapy
with a unique biomechanical device.
Trial registration: Registration number NCT01562652.
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Osteoarthritis (OA) is the most prevalent form of arth-
ritis [1]. About 6% of Asian males and 12% of Asian fe-
males suffer from knee OA [2]. The prevalence of OA
increases with age and generally affects women more
frequently than men. The population of many Asian
countries are ageing rapidly, and it is estimated that be-
tween 2008 and 2040, the proportion of the Singaporean
population aged 65 years old and over will increase by
316% [3]. Hence, the prevalence of knee OA is expected
to rise.
Knee OA is associated with symptoms of pain, func-
tional disability and deteriorated quality of life that
might lead to further morbidity; 10% of Asian males and
13% of Asian females report knee pain [2]. From a social
perspective, OA is costly, having high direct costs in the
form of increased utilization of hospital and medical ser-
vices and also high indirect costs through lost productivity
of individuals [4,5]. Therefore, researchers are constantly
trying to find effective treatments that will help to halt the
disease progression and even reverse it.
Patients with knee OA demonstrate pathological gait
patterns compared to age-matched controls [6,7]. Specific-
ally, patients with knee OA demonstrate a deterioration in
spatio-temporal gait parameters including slower walking
velocity, shorter step length and shorter single-limb sup-
port (SLS) compared to matched controls [6,8]. Recent
studies have reported an association between the level of
symptoms (i.e. pain and functional limitation) of knee
OA patients and their gait pattern [9]. Elbaz et al.
have published a new objective functional classifica-
tion of patients with knee OA which is based on the
patient’s ability to bear single loads on one knee while
the contralateral leg swings forward (i.e. single limb
support) [10]. This new classification is thought to give a
clearer description of the patient’s functional condition
than radiographic findings, considering the knowledge
that the correlation between symptoms and radiographic
changes is poor [9,11].
Several non-invasive interventions exist for knee OA;
amongst them are biomechanical interventions. Previous
studies have shown the effect of several biomechanical
interventions focused on foot centre of pressure manipu-
lation and agility and perturbation training in patients
with knee OA [12-17]. A relatively new biomechanical
intervention for patients with knee OA was introduced.
This intervention incorporates a personalized foot-worn
biomechanical device and treatment methodology for pa-
tients with knee OA (AposTherapy). Recent studies have
found that patients with knee OA who underwent this
intervention reported significant improvements in the
levels of pain and function [12,13]. Furthermore, improve-
ments were also found in the gait patterns of these pa-
tients, muscle activation patterns [18] and knee adductionmoment, which is highly associated with disease severity
[14]. All of the abovementioned articles were conducted
on a Caucasian western population, and information re-
garding the effect of this therapy on the Asian population
is missing. The purpose of this study was to evaluate the
effect of this special intervention on the level of symptoms
and gait patterns in a multi-ethnic Singaporean population
suffering from knee OA.
Methods
Participants
Sixty-eight patients were assessed at baseline. Ten pa-
tients were excluded as they did not meet the inclusion
criteria. Overall, 58 patients (39 females and 19 males)
diagnosed with primary medial compartment knee OA
participated in this study, and 54 patients completed it
(Figure 1). Ninety-five percent of the patients (49 pa-
tients) had bilateral knee OA. The mean (standard devi-
ation (SD)) age was 59.7 (6.1) years and mean (SD) body
mass index (BMI) was 30.7 (14.6) kg/m2. Forty-four pa-
tients (82%) were Chinese, five patients (9%) were Indian
and five patients (9%) were Malay. Patients’ structural OA
severity was determined by the Kellgren and Lawrence
(KL) score [19]. Twenty patients (37.0%) were graded 2,
21 patients (38.9%) were graded 3 and 13 patients (24.1%)
were graded 4.
Patients were referred to the therapy centre by their
physician after being diagnosed with primary medial
compartment knee OA. The study protocol was ap-
proved by Parkway Independent Ethic Committee and
is registered in clinicaltrial.gov website (registration
number NCT01562652). All patients signed their in-
formed consent after understanding the study’s objec-
tives and protocol. Inclusion criteria were (1) patients
suffering from symptomatic bilateral knee OA at the
medial compartment for at least 6 months, fulfilling
the American College of Rheumatology clinical criteria
for OA of the knee [20], and having radiographically
assessed OA of the knee classified according to Kellgren
and Lawrence score [19]; (2) males and females above
50 years old.
Exclusion criteria were (1) patients suffering from
acute septic arthritis, (2) patients suffering from inflam-
matory arthritis, (3) patients who received a corticosteroid
injection within 3 months of the study, (4) patients suffer-
ing from avascular necrosis of the knee, (5) patients with a
history of knee buckling or recent knee injury, (6) patients
who have had a joint replacement, (7) patients suffering
from neuropathic arthropathy, (8) patients with an in-
creased tendency to fall (more than three falls in the last
year), (9) patients with a history of pathological osteopor-
otic fracture and (10) patients suffering from severe symp-
tomatic degenerative arthritis in lower limb joints other
than the knees.
68 patients were assessed for eligibility
58 patients completed baseline measurements
and commenced treatment
10 patients were excluded:
Severe back pain – 3 patients
Age – 2 patients
Lack of symptoms – 2 patients
Not interested - 2 patients
Gout – 1 patient
54 patients were assessed at 1st follow-up
(3 months)
4 patients dropped:
No compliance – 2 patients
Relocation – 1 patient
Total knee replacement – 1 patient
54 patients were assessed at the end of study
(6 months)
Figure 1 Flow chart of assessment, enrolment and follow-up.
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A computerized mat was used to measure spatio-
temporal gait parameters (GaitMat™ II system, E.Q., Inc.
Chalfont, PA, USA). The validity and reliability of the
electronic gait mat was reported previously [21]. During
the gait test, all patients walked barefoot at a self-
selected speed. Patients walked 3 m before and after
the walkway mat to allow sufficient acceleration and
deceleration time outside the measurement area. Each
gait test included six walks, and the mean value of
the six walks was calculated for each parameter. The
following spatio-temporal parameters were evaluated:
velocity (cm/s), step length (cm), stance phase (% gait
cycle) and SLS phase (% gait cycle).
Self-reported questionnaires
To examine changes in pain, function and quality of life
perception, the translated Singaporean version of the
Western Ontario and McMaster Universities Arthritis
Index (WOMAC) questionnaire [22,23] and SF-36 Health
Survey [24,25] were evaluated. The WOMAC questionnaire
is a visual analogue scale (VAS) ranging from 0 to 10 cm,with 0 cm indicating no pain or limitation in function and
10 cm indicating the most severe pain or limitation in
function. The questionnaire contains 24 questions of
which 5 evaluate pain, 2 evaluate joint stiffness and 17
evaluate function. The SF-36 is scored between 0 and 100,
with 0 indicating the worst quality of life and 100 indicat-
ing the best quality of life. The questionnaire contains 36
questions of which two subscales are calculated to give a
physical and mental score. The physical score is composed
of questions regarding physical health, role limitation due
to physical problems, pain, general health and vitality. The
mental score is composed of questions in the fields of gen-
eral health, vitality, social functioning, role limitation due
to emotional problems and emotional well-being.
Intervention
A novel foot-worn biomechanical device (Apos System,
APOS—Medical and Sports Technologies Ltd. Herzliya,
Israel) comprising convex adjustable pods placed under
the hindfoot and forefoot regions of each foot was used.
This device enables customized calibration of the pods
(i.e. biomechanical elements) which allows manipulation
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hence enabling control of the external forces (i.e. coronal
and sagittal moments) acting on the knee joint [26-28].
Furthermore, the convexity of the biomechanical ele-
ments promotes minor perturbation throughout all
phases of the step cycle (Figure 2) and trains neuromuscu-
lar control [29].
Study protocol
Prior to each assessment, patients were instructed not to
consume pain medication for at least 72 h in order to
eliminate the effect of these medications on the patient’s
pain levels and gait patterns. Anthropometric measure-
ments were taken at baseline. All patients underwent a
gait test on the computerized mat and completed the
WOMAC questionnaires and the SF-36 Health Survey
during each visit to the therapy centre. After the com-
pletion of the baseline measurements, the biomechanical
device was individually calibrated to each patient by a
physiotherapist certified in the AposTherapy method-
ology. Patients received exercise guidelines from the
therapist. They were instructed to put on the device and
go about their daily activities for 10 min once a day
(accumulating 5-min walks) during the first week andFigure 2 Apos System. (a) Biomechanical device comprising two individu
attached to a platform under the hindfoot and forefoot regions. (b) The bi
and resilience. (c) The specially designed sole of the platform includes two
of each biomechanical element.gradually increasing to 60 min once a day (accumu-
lating between 25- and 30-min walks) for the rest of
the treatment period. Patients were re-evaluated after
3 and 6 months of treatment. Patients were instructed
not to consume any other treatment modalities dur-
ing the study period including physical therapy, injec-
tions and NSAIDs.
Statistical analysis
All spatio-temporal gait parameters and self-evaluation
questionnaire scores were presented as mean (SD),
followed by 95% confidence interval for all time periods.
Non-parametric one-sample Kolmogorov-Smirnov tests
were calculated to compare the observed cumulative dis-
tribution function for the continuous variables with the
normal theoretical distribution. The general linear model
repeated measures procedure was used to provide ana-
lysis of variance for gait parameters and self-evaluation
questionnaires when the same measurement was made
three times on each subject. Repeated measures ANOVA
were conducted by subgroups to demonstrate the sensi-
tivity of the results. Data were analyzed with IBM SPSS
software version 19.0, and the significance level was set
at 0.05.ally calibrated elements and a foot-worn platform. The elements are
omechanical elements are available in different degrees of convexity
mounting rails and a positioning matrix to enable flexible positioning
Figure 3 Changes in WOMAC pain, stiffness and function following
6 months of therapy. The WOMAC questionnaire includes 24 questions
in a VAS format (0 = no pain/stiffness/difficulty, 10 = severe pain/stiffness/
difficulty).
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Fifty-four patients out of fifty-eight recruited patients
completed the study (93.1%). Four patients did not
complete the study: two patients did not comply with
the treatment, one patient relocated and could not con-
tinue with therapy and one patient chose to undergo a
total knee replacement. All remaining patients complied
with the treatment, and there were no reports of any ad-
verse events during the treatment period.
All spatio-temporal gait parameters significantly im-
proved following 3 months of therapy except for SLS
phase of the less symptomatic knee. After 6 months of
therapy, all parameters improved significantly compared
to baseline. Specifically, gait velocity improved by 15.9%,
step length of the more symptomatic knee improved by
10.3%, the stance phase of the more symptomatic knee
decreased by 5.9% and the SLS phase of the more symp-
tomatic knee increased by 2.7%. The changes in gait pa-
rameters throughout the treatment are summarized in
Table 1.
The results of the self-evaluation questionnaires im-
proved significantly over time. The following are the re-
sults of all subcategories of the WOMAC questionnaires:
WOMAC pain decreased by 68.3%, WOMAC stiffness
decreased by 66.7% and WOMAC functional limita-
tion decreased by 75.6% following 6 months of therapy
(P < 0.001 for all). Figure 3 illustrates the changes over
time in the three WOMAC subcategories.
All of the SF-36 subscales improved significantly fol-
lowing 3 months of therapy except for emotional well-
being. The SF-36 physical score (average of five physical
subscales) and the SF-36 mental score (average of five
mental subscales) increased significantly over time. After
6 months of therapy, all subscales improved significantlyTable 1 Changes in spatio-temporal gait parameters followin
Parameter Baseline
Velocity (cm/s) 86.9 (16.4)
[82.4–91.3]
Step length MS (cm) 49.4 (7.9)
[47.3–51.6]
Step length LS (cm) 50.0 (7.5)
[48.0–52.1]
Stance MS (% GC) 71.4 (7.3)
[69.4–73.3]
Stance LS (% GC) 72.8 (7.4)
[70.7–74.8]
Single-limb support MS (% GC) 37.2 (2.6)
[36.5–37.9]
Single-limb support LS (% GC) 38.7 (2.3)
[38.1–39.4]
Results are presented as mean (SD) [95% CI]. MS more symptomatic, LS less symptoexcept for emotional well-being. Summarized results are
presented in Table 2.
A further analysis was conducted on the SLS phase
changes. We evaluated the changes in SLS based on
Elbaz et al.’s functional severity classification of knee OA
[10]. According to this classification, SLS is divided into
five groups, each indicating a different functional sever-
ity level. Patients who fall into Q1 are characterized with
poor walking abilities and high levels of pain and func-
tional limitation, and patients who fall into Q5 are char-
acterized with normal walking abilities and low levels of
pain and functional limitation. At baseline, 11.1% of the
patients fell into Q1, 7.5% fell into Q2, 25.9% fell into
Q3, 22.2% fell into Q4 and 33.3% of the patients fell into
Q5. After 6 months of therapy, a considerable shift was
noticed: 5.5% of the patient fell into Q1, 5.5% fell into
Q2, 11.1% fell into Q3, 25.9% fell into Q4 and 52.0% of
the patients fell into Q5.g 6 months of therapy
3 months 6 months P value
98.8 (16.1) 100.7 (16.5) <0.001
[94.4–103.2] [96.2–105.2]
53.7 (7.3) 54.5 (7.5) <0.001
[51.7–55.7] [52.5–56.6]
54.0 (7.2) 54.7 (7.8) <0.001
[52.0–56.0] [52.6–56.8]
67.3 (6.9) 67.2 (7.4) <0.001
[65.4–69.2] [65.2–69.2]
67.2 (8.1) 67.4 (6.5) <0.001
[65.0–69.5] [65.6–69.2]
37.2 (2.5) 38.1 (2.5) 0.001
[37.5–38.8] [37.4–38.8]
39.0 (1.9) 39.2 (1.9) 0.027
[38.5–39.5] [38.7–39.7]
matic, GC gait cycle. Set P < 0.05.
Table 2 Changes in SF-36 quality of life following 6 months of therapy
Parameter Baseline 3 months 6 months P value
Physical function 45.2 (20.1) 56.9 (19.7) 61.9 (21.5) <0.001
[39.7–50.7] [51.6–62.3] [56.0–67.7]
Limitation due to physical health 29.8 (34.0) 55.3 (42.4) 75.0 (33.6) <0.001
[20.4–39.3] [43.5–67.1] [65.7–84.3]
Limitations due to emotional problems 59.8 (44.5) 71.8 (39.8) 84.6 (28.4) <0.001
[47.4–72.2] [60.7–82.9] [76.7–92.5]
Vitality 52.5 (17.2) 58.9 (17.0) 60.3 (17.8) 0.004
[47.8–57.2] [54.2–63.5] [55.4–65.1]
Emotional well being 68.0 (10.9) 69.9 (11.7) 71.0 (9.5) 0.061
[65.1–71.0] [66.7–73.0] [68.5–73.6]
Social functioning 65.6 (22.9) 73.8 (21.9) 75.7 (19.9) 0.004
[59.3–71.8] [67.9–79.8] [70.3–81.2]
Pain 48.3 (20.0) 63.4 (20.7) 62.3 (21.3) 0.001
[42.8–53.8] [57.7–69.0] [56.4–68.1]
General health 50.5 (19.1) 60.1 (19.1) 66.3 (17.1) <0.001
[44.3–55.7] [54.9–65.3] [61.6–70.9]
Physical Score 44.7 (14.5) 59.0 (18.0) 65.3 (17.7) <0.001
[40.8–48.7] [54.1–64.0] [60.5–70.1]
Mental Score 58.5 (16.0) 67.0 (16.3) 71.7 (13.4) <0.001
[54.2–62.9] [62.5–71.4] [68.0–75.3]
SF-36 Health Survey includes 36 questions. Results range between 0 and 100 (0 = poor quality of life, 100 = high quality of life). Set P < 0.05.
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on the level of improvement following treatment. A sen-
sitivity analysis divided the cohort into two groups based
on their BMI values (below/above 26.4 which represents
the median). A second analysis divided the cohort into
two groups based on their KL grade (KL 1–2 and KL 3–4).
We examined the changes in the measured variables in
each subgroup. In the BMI subgroup analysis, most of
the variables maintained the trend and improved sig-
nificantly, except for SLS of the less symptomatic leg
in both BMI subgroups. Furthermore, the following
SF-36 subcategories of the heavier BMI group became
non-significant: vitality, social functioning and pain.
In the KL grade subgroup analysis, most of the vari-
ables maintained the trend and improved significantly,
except for the SLS of the more and less symptomatic
leg and the vitality subcategory of the SF-36 in the
more severe KL group. Furthermore, the social func-
tioning subscale of SF-36 in the less severe KL group
also became non-significant.
Discussion
The purpose of the present study was to evaluate the ef-
fect of a non-invasive foot-worn biomechanical device
on the spatio-temporal gait patterns, level of pain, func-
tion and quality of life of Singaporean patients suffering
from medial compartment knee OA. Following 3 monthsof therapy, patients demonstrated an improvement in gait
patterns and alleviation in symptoms. Patients maintained
these improvements after 6 months of therapy. The im-
provement in gait pattern was accompanied by a reduc-
tion in pain and joint stiffness and with an increase in
function and quality of life. All of the SF-36 quality of
life subcategories improved significantly except for emo-
tional well-being (P = 0.06). A possible explanation might
be the relatively high pre-treatment value of the study
population. These results support previous prospective
studies that examined this therapy on a western Caucasian
population. Bar-Ziv et al. reported a 65% reduction in pain
and a 63% reduction in functional disability following 2
months of AposTherapy [13]. Haim et al. reported a
61% reduction in pain and a 63% reduction in func-
tional disability following 9 months of AposTherapy
[14]. Patients in the current study reported a mean
reduction of 68% in pain and a mean reduction of
76% in functional disability following 6 months of
therapy. In addition, the reduction in pain and func-
tional disability and the improvement in quality of life
in the current study met with the OMERACT-OARSI
criteria and that of Angst et al. for the amount of im-
provement needed to assure clinical significance to
the patient [30,31]. Based on this, it may be assumed
that the examined therapy in the current study might
have a positive effect on the level of pain and functional
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knee OA.
Currently, the management of knee OA focuses on alle-
viating the patient’s symptoms, which is usually monitored
using self-reported questionnaires. Since questionnaires
are subjective, there is a need for an objective evaluation
tool to help assess symptoms. Recently, it has been sug-
gested that computerized gait analysis might serve as a
good indicator for functional severity. Elbaz et al. pre-
sented an objective functional severity classification which
is based on the patient’s ability to bear loads on the painful
knee (SLS) [10]. It is assumed that the ability of a patient
to bear loads on the painful knee will decrease as pain
level increases, which will also compromise the patient’s
functional abilities. In the current study, we examined the
changes in SLS following therapy based on the abovemen-
tioned classification. At baseline, only 35% of the patients
were placed at the fifth quintile, which corresponds with
low levels of pain and functional disability. After 6 months
of therapy, 52% of the patients were placed at the fifth
quintile. These results objectively support the patient’s
perception and strengthen the notion of reduced pain and
improved function.
The presentation of spatio-temporal gait parameters
can be either in absolute values (s) or as percentage of
gait cycle time (% GC) [32]. A reduction in the absolute
stance phase time is considered to reflect an antalgic
gait. However, an increase in the relative stance phase
represents an abnormal gait pattern that usually charac-
terizes knee OA in patients [33]. It is important to
stress that in the current study, patient’s had above-
normal stance phase values (% GC) before commencing
treatment. Following treatment, a reduction in stance
was noted. The reduction in stance phase was accom-
panied with an increase in gait velocity bringing the
patient closer to normal values and maintaining sym-
metry [33,34]. We therefore considered the reduction
in stance phase a positive outcome.
We examined the effect of BMI and KL grade on the
examined gait parameters and questionnaires. BMI and
KL grade had a minor effect on the results following a
sensitivity analysis and did not affect the significant im-
provement in pain and function. In the BMI sensitivity
analysis, P values were close to significant; therefore, we
believe that this trend was not due to BMI difference be-
tween patients. Similar to the BMI sensitivity analysis,
the results in the KL sensitivity analysis are also probably
due to a small sample size and not directly because of
the KL grade. This corresponds with other publication
that reported poor correlation between knee symptoms
and radiographic grading [9]. In order to better under-
stand the effect of BMI and KL grading on the outcomes
of this treatment, we recommend that a larger cohort
should be examined.This study has some limitations. Firstly, the study
lacked a control group. A previous study, however, by
Bar-Ziv et al. [13] had already demonstrated the positive
effect of this therapy compared to a control group in a
double-blind study. Secondly, this study did not include
radiographic assessment of the patients’ knees. Radio-
graphic evaluation of structural changes in the knee joint
is an integral process in knee OA assessment. The cor-
relation, however, between structural severity and knee
OA symptoms is poor [9]. Thirdly, the study examined
patients with medial compartment knee OA; hence, the
results are applicable for this type of knee OA. Further-
more, this study included patients with severe degenera-
tive changes to the knee joint which may bias the results
as other compartments of the knee are also involved. Fu-
ture studies should examine the effect of this therapy on
structural changes at the knee joint and should also
examine the effect of this therapy in patients with lat-
eral/anterior knee OA and in patients with different
knee alignment (varus/valgus). Lastly, follow-up period
was relatively short. A recent long-term follow-up study
by Bar-Ziv et al. demonstrated maintenance of improved
symptoms in patients with medial knee OA [35]; how-
ever, this should be applied on the Singaporean popula-
tion and include gait assessment.
Conclusions
Singaporean population with medial compartment knee
OA demonstrated improved gait patterns, reported alle-
viation in symptoms and improved function and quality
of life following 6 months of AposTherapy. The results
of this study support previous works that examined the
effect of this therapy on western population. Based on the
results of this study, it may be assumed that this therapy
might have a positive effect on patients with knee OA and
should be considered as an additional treatment modality
in the management of knee OA.Competing interests
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